Prostate Cancer - Mar 22, 2018 Edition

Health News and Information - News Medical

March 22, 2018 Prostate Cancer The latest prostate cancer news from News Medical

PSA screening for prostate cancer is not effective, report researchers According to a new study, the one-off PSA screening test for prostate cancer does not save lives of asymptomatic men.

Study reveals impact of prostate cancer on wives and partners of sufferers Many wives of advanced prostate cancer sufferers feel that their lives are being undermined by their husband's illness, with nearly half reporting that their own health suffered. Multimodal treatment approach enhances long-term survival in men with metastatic prostate cancer UCLA researchers have discovered that a combination of high doses of radiotherapy and hormonal therapy provides the best chance of decreasing the mortality rate in men with aggressive prostate cancer.

Southern Research scientists target mutated protein to combat prostate cancer Southern Research scientists are exploring how a mutated protein implicated in prostate cancer plays a role in the development of the disease and whether it holds a key to better treatment outcomes. Protein profiling reveals new prostate cancer mechanisms A study by the University of Tampere in Finland used protein profiling to find new prostate cancer mechanisms that are not shown by aberrations at the genomic level. Several new potential biomarkers of prostate cancer were also found. Higher doses of radiation do not translate into longer survival for prostate cancer patients A new study shows that higher doses of radiation do not improve survival for many patients with prostate cancer, compared with the standard radiation treatment. International study shows benefits of using MRI at the start of prostate cancer diagnosis A large international study has shown that an MRI scan can reduce the number of invasive prostate biopsies by up to 28%. The PRECISION trial shows that using MRI to target prostate biopsies leads to more of the harmful prostate cancers, and fewer harmless cancers being diagnosed. What are Antiandrogens? Antiandrogens are a group of medications which bind to intracellular androgen receptors (AR) to prevent androgen effects on organs such as the testes, the hair follicles, the hypothalamus, pituitary, ovaries and the prostate gland, which are targets of endogenous androgens. They are used to treat a variety of clinical conditions which are characterized by hyperandrogenism, such as acne, hirsutism, and prostate cancer.

Website: www.news-medical.net Email: info@news-medical.net Telephone: +44 (0)161 457 7150 AZoNetwork UK Ltd. NEO, 4th Floor 9 Charlotte Street, Manchester M1 4ET, UK